PNP Therapeutics, Inc. Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama. http://www.pnptherapeutics.com/

Australian Cancer Technology Pty Ltd Company developing three approaches for cures; Chk1 kinase inhibitor, mutated p53 gene and retroviral display vaccines. Includes announcements, media releases, overview of projects incollaboration with UK, a hospital in Sydney, and corporate details at West Perth, Western Australia. http://www.austcancer.com.au/

Onyvax Ltd. Conducts research and development for marketing cell-based vaccines and human monoclonal antibody against CD55 in tumour cells. Includes explanation of products in pipeline, and clinical studies in phase II of prostate cancer vaccine at Bournemouth, and their contacts in London, UK. http://www.onyvax.com/

Aventis Cancer Vaccine Program Studying the possibilities of using an immunotherapeutic approach for melanoma, breast and colorectal and tumors. Includes results of clinical research, FAQ, contact form, and profile of research partners in Canada. http://www.cancervaccines.com/

Biomoda, Inc. Offers products for diagnosis, imaging and treatment of tumors, especially in lung. Technologies in sputum sample and pap smear screening, certifying cell lines, inflammatory focus imaging, Cu-TCPP treatment in pre-clinical development at Albuquerque, New Mexico. http://www.biomoda.com/

Crusade Laboratories Ltd. Start-up focusing on the discovery, development and commercialisation of novel treatments for tumors and neurodegenerative diseases. Includes investor information, technology in GM-HSV targeting glioma and clinical trials in Glasgow, UK. http://www.crusadelabs.co.uk/

Cancer Survival Toolbox Introduction the mechanisms, with resources in oncology, vascular medicine and immunolgical disease, including possible therapies and links to related organizations, presented by Genentech, Inc. http://www.gene.com/gene/products/education/oncology/cst/

Bath Cancer Research Offers cytotoxicity screening for potential drugs, and ex vivo drug sensitivity cell testing, for non-Hodgkin's lymphoma, chronic and acute leukaemias, to haematologists and oncologists, as an international service from Bath, UK. http://www.caltri.org/

InterGenetics Inc. Company with platform technology, called CombiSNiP, that genetically quantifies an individual's risk for development, and is involved in pharmacogenetics research on treating breast cancer. Includes corporate overview, directions and contacts in Oklahoma City. http://www.intergenetics.com/index1.html

GeneSegue Focusing on the development of delivery systems to target solid tumors, such as prostate with nanoencapsulated biotherapeutics. Includes brief overview of concepts from Chaska, Minnesota. http://www.genesegues.com/

Karyon Offers products in angiogenesis and cell growth regulation, focusing on protected ligands that target specifically to sarcomas and melanomas. Includes research and technology overview, and information for investors in Helsinki, Finland. http://www.karyon.fi/

Celtic Biotech, Inc. Develops products from the proof of concept stage to clinically viable in vitro diagnostics, in the fields of oncology and immunology. Includes patents, related publication list and profile of company in Utah. http://www.celticbio.com/

Hannah Cell Science Offer analytical services and research partnerships in cell biology focusing on mammalian mammary gland, with applications in breast cancer and lactation. Includes examples of cytotoxicity screening, phenotyping, molecular interactions and binding studies in Ayr, Scotland. http://www.hannahcellscience.com/

Dominion Pharmakine Preclinical-stage biopharmaceutical company that designs, develops and commercializes technologies for cancer metastasis research and treatment. Worldwide news, products and contacts in Bizkaia, Spain. http://www.pharmakine.com/

Amynon Biotech GmbH. Develops compounds for the diagnosis of viral and non-viral induced tumour-related diseases in Innsbruck, Austria. http://www.amynon.com/

Oncogene Science Diagnostic and therapeutic products relating to prostate specific antigen and oncoproteins, within a division of Bayer in Cambridge, Massachusetts http://www.oncogene.com/

Altarex Corp. Focused on photoactivation and multi-epitopic development of foreign antibodies that activate and modulate the immune system for the treatment of ovarian tumors and multiple myeloma. Profile of company, clinic and science, with investor data and contacts at University of Alberta, Edmonton, Canada. http://www.altarex.com/

Pivotal BioSciences, Inc. Management and pipeline of cancer therapeutics licensed from the University of Southern California Keck School of Medicine in Los Angeles, California. http://www.pivotalbiosciences.com/

Topotarget Oncology studies in small molecule histone deacetylase and topoisomerase II inhibitors, with clinical trials in solid tumours, CNS and extravasation. Technology and profile of company with facilities in Copenhagen and Abingdon, England. http://www.topotarget.com/

AC Immune SA. Focus on CNS conformational diseases and oncology, using a combination of antibodies produced to non-covalent complexes of peptide sequences, presented as liposomes. Technical and corporate overviews of company in Lausanne, Switzerland. http://www.acimmune.com/